BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33906263)

  • 1. Biomarker-guided heterogeneity analysis of genetic regulations via multivariate sparse fusion.
    Zhang S; Hu X; Luo Z; Jiang Y; Sun Y; Ma S
    Stat Med; 2021 Jul; 40(17):3915-3936. PubMed ID: 33906263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide algorithm for detecting CNV associations with diseases.
    Xu Y; Peng B; Fu Y; Amos CI
    BMC Bioinformatics; 2011 Aug; 12():331. PubMed ID: 21827692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaussian graphical model-based heterogeneity analysis via penalized fusion.
    Ren M; Zhang S; Zhang Q; Ma S
    Biometrics; 2022 Jun; 78(2):524-535. PubMed ID: 33501648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assisted gene expression-based clustering with AWNCut.
    Li Y; Bie R; Teran Hidalgo SJ; Qin Y; Wu M; Ma S
    Stat Med; 2018 Dec; 37(29):4386-4403. PubMed ID: 30094873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting Population-Differentiation Copy Number Variants in Human Population Tree by Sparse Group Selection.
    Zhang H; Roe D; Kuang R
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(2):538-549. PubMed ID: 29990238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation subgroup and molecular heterogeneity is a hallmark of glioblastoma: implications for biopsy targeting, classification and therapy.
    Gempt J; Withake F; Aftahy AK; Meyer HS; Barz M; Delbridge C; Liesche-Starnecker F; Prokop G; Pfarr N; Schlegel J; Meyer B; Zimmer C; Menze BH; Wiestler B
    ESMO Open; 2022 Oct; 7(5):100566. PubMed ID: 36055049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological imaging-based cancer heterogeneity analysis via penalized fusion with model averaging.
    He B; Zhong T; Huang J; Liu Y; Zhang Q; Ma S
    Biometrics; 2021 Dec; 77(4):1397-1408. PubMed ID: 32822084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust analysis of cancer heterogeneity for high-dimensional data.
    Cheng C; Feng X; Li X; Wu M
    Stat Med; 2022 Nov; 41(27):5448-5462. PubMed ID: 36117143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-Specific eQTL in Zebrafish.
    Dobrinski KP
    Methods Mol Biol; 2020; 2082():239-249. PubMed ID: 31849020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust network-based analysis of the associations between (epi)genetic measurements.
    Wu C; Zhang Q; Jiang Y; Ma S
    J Multivar Anal; 2018 Nov; 168():119-130. PubMed ID: 30983643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Method for Detecting Associations with Rare Copy-Number Variants.
    Tzeng JY; Magnusson PK; Sullivan PF; ; Szatkiewicz JP
    PLoS Genet; 2015 Oct; 11(10):e1005403. PubMed ID: 26431523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Sparse Model Based Detection of Copy Number Variations From Exome Sequencing Data.
    Duan J; Wan M; Deng HW; Wang YP
    IEEE Trans Biomed Eng; 2016 Mar; 63(3):496-505. PubMed ID: 26258935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1 germline copy number variations and melanoma susceptibility.
    Rocca MS; Benna C; Mocellin S; Rossi CR; Msaki A; Di Nisio A; Opocher G; Foresta C
    J Transl Med; 2019 May; 17(1):181. PubMed ID: 31142321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Sparse Learning Framework for Joint Effect Analysis of Copy Number Variants.
    Wang Z; Hall B; Xu J; Shi X
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(5):1013-1027. PubMed ID: 28991724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cancer gene expression data with an assisted robust marker identification approach.
    Chai H; Shi X; Zhang Q; Zhao Q; Huang Y; Ma S
    Genet Epidemiol; 2017 Dec; 41(8):779-789. PubMed ID: 28913902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring DNA Copy Number Variation Using High-Density Methylation Microarrays.
    Cho S; Kim HS; Zeiger MA; Umbricht CB; Cope LM
    J Comput Biol; 2019 Apr; 26(4):295-304. PubMed ID: 30789293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide copy number variations as molecular diagnostic tool for cutaneous intermediate melanocytic lesions: a systematic review and individual patient data meta-analysis.
    Ebbelaar CF; Jansen AML; Bloem LT; Blokx WAM
    Virchows Arch; 2021 Oct; 479(4):773-783. PubMed ID: 33851238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noise cancellation using total variation for copy number variation detection.
    Zare F; Hosny A; Nabavi S
    BMC Bioinformatics; 2018 Oct; 19(Suppl 11):361. PubMed ID: 30343665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SubPatCNV: approximate subspace pattern mining for mapping copy-number variations.
    Johnson N; Zhang H; Fang G; Kumar V; Kuang R
    BMC Bioinformatics; 2015 Jan; 16():16. PubMed ID: 25591662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.